A multicenter randomized, double-blind, placebo-controlled pilot study to assess the efficacy and safety of riociguat in systemic sclerosis-associated digital ulcers

BACKGROUND: To determine the effect of riociguat, an oral, selective soluble guanylate cyclase stimulator, on the net digital ulcer (DU) burden in systemic sclerosis (SSc). METHODS: Participants with SSc-related active or painful indeterminate DUs were recruited in a multicenter, double-blind, rando...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arthritis Res Ther
Hauptverfasser: Nagaraja, Vivek, Spino, Cathie, Bush, Erica, Tsou, Pei-Suen, Domsic, Robyn T., Lafyatis, Robert, Frech, Tracy, Gordon, Jessica K., Steen, Virginia D., Khanna, Dinesh
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2019
Schlagworte:
Research Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6724329/
https://ncbi.nlm.nih.gov/pubmed/31481106
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13075-019-1979-7
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge